MedPath

Use of silver nanoparticles for the treatment of pyorrhea

Phase 3
Not yet recruiting
Conditions
Chronic periodontitis,
Registration Number
CTRI/2019/04/018718
Lead Sponsor
Research Cell KGMU
Brief Summary

25 patients with chronic periodontitis will be recruited for the study. A split mouth randomized study will be conducted where the drug will be given in one quadrant of the patient’s mouth along with scaling and root planning and the contralateral side will be treated with scaling and root planing along with pacebo. The patients will be selected in such a way that both sides of the mouth are equally affected by chronic periodontits.  The patient’s Gingival index, papillary bleeding index, probing pocket depth and clinical attachment gain will be recoreded at baseline, 1 month and then 3 months.

The patient’s gingival crevicular fluid will be collected at baseline,1 month and 3 months for its biochemical assay in order to assess the change in the level of interleukin 1 beta. The drug will be delivered in the periodontal pocket. This will be done in order to understand the clinical as well as the anti-inflammatory action of silver nanoparticles. If the outcome of the study will be positive it will be ascertained that Silver nanoparticles aid scaling and root planing in the treatment of chronic periodontitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

1.25-50 years of age 2.Probing pocket depth ≥ 5mm 3.Systemically healthy patients 4.No history of periodontal therapy in the last 6 months.

Exclusion Criteria
  • Pregnant or lactating women 3.
  • Allergic to silver metal.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Use of Silver nanoparticles as an adjunct to scaling and root planing1 month
Secondary Outcome Measures
NameTimeMethod
Use of Silver nanoparticles as an adjunct to scaling and root planing3 months

Trial Locations

Locations (1)

King George Medical University

🇮🇳

Lucknow, UTTAR PRADESH, India

King George Medical University
🇮🇳Lucknow, UTTAR PRADESH, India
Dr Ishita Joshi
Principal investigator
8851928717
ijoshi7@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.